Does Ubs own SNDX stock?

Yes. As of its Q2 2026 13F, Ubs holds 1,893,750 shares of SNDX (Syndax Pharmaceuticals), worth $41.4M.

How many shares of SNDX does Ubs own?

As of its Q2 2026 13F, Ubs holds 1,893,750 shares of SNDX (Syndax Pharmaceuticals).

As of its Q2 2026 13F, Ubs' SNDX position is worth $41.4M.

In Q2 2026, Ubs increased its SNDX position by 740,088 shares (+64.2%).

Ubs already held SNDX in its Q1 2019 13F, the earliest on record, and has listed it in 30 quarterly 13F filings.

Position history for UBS Group AG's holdings in SYNDAX PHARMACEUTICALS INC

Current Value

$41.4M

Current Shares

1.9M

Total Value Change

+$41.4M

Total Shares Change

+1.9M

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1.9M	+64.2%	$41.4M	0.0%	$21.86	42
2026-Q1	Increased	1.2M	+61.1%	$26.9M	0.0%	$21.40	41
2025-Q4	Decreased	716,219	-57.2%	$15M	0.0%	$20.74	0
2025-Q3	Increased	1.7M	+16.7%	$25.8M	0.0%	$15.56	33
2025-Q2	Decreased	1.4M	-16.3%	$13.4M	0.0%	$9.04	0
2025-Q1	Increased	1.7M	+66.8%	$21.1M	0.0%	$13.18	42
2024-Q4	Increased	1M	+602.6%	$13.6M	0.0%	$12.52	45
2024-Q3	Increased	146,438	+17.0%	$2.8M	0.0%	$18.89	31
2024-Q2	Decreased	125,152	-53.6%	$2.6M	0.0%	$20.53	0
2024-Q1	Decreased	269,811	-7.2%	$6.4M	0.0%	$23.80	0
2023-Q4	Increased	290,801	+285.9%	$6.3M	0.0%	$21.61	44
2023-Q3	Decreased	75,357	-33.1%	$1.1M	0.0%	$14.52	0
2023-Q2	Increased	112,716	+4.1%	$2.4M	0.0%	$20.47	27
2023-Q1	Decreased	108,315	-37.3%	$2.3M	0.0%	$20.66	0
2022-Q4	Decreased	172,785	-39.5%	$4.4M	0.0%	$25.45	0
2022-Q3	Decreased	285,532	-9.8%	$6.9M	0.0%	$24.71	0
2022-Q2	Increased	316,675	+47.2%	$6.1M	0.0%	$19.08	37
2022-Q1	Increased	215,164	+53.1%	$3.7M	0.0%	$17.25	37
2021-Q4	Increased	140,517	+99.3%	$3.1M	0.0%	$21.78	43
2021-Q3	Increased	70,513	+283.8%	$1.3M	0.0%	$19.56	41
2021-Q2	Decreased	18,372	-71.0%	$315,000	0.0%	$17.41	0
2021-Q1	Increased	63,372	+443.3%	$1.4M	0.0%	$20.96	41
2020-Q4	Increased	11,664	+1066.4%	$260,000	0.0%	$22.85	37
2020-Q3	Decreased	1,000	-96.7%	$15,000	0.0%	$14.02	0
2020-Q2	Increased	30,063	+89.3%	$446,000	0.0%	$14.46	38
2020-Q1	Decreased	15,877	-38.5%	$174,000	0.0%	$10.62	0
2019-Q4	Increased	25,795	+18.3%	$227,000	0.0%	$8.85	27
2019-Q3	Increased	21,805	+284.6%	$163,000	0.0%	$7.74	36
2019-Q2	Increased	5,669	+183.4%	$53,000	0.0%	$9.31	23
2019-Q1	First report	2,000	-	$11,000	0.0%	$5.25	0